| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUUUCUUAUGCAGAAAGUGCUGAGCAACGGACAGACUGAAGAGGUUAGG… | 3741 nt | 0.4133 | |
| AGUCUGGCGGCGGCUGCCGUGAGCUGACUGACGUUCCGGGAACGCCGCA… | 3756 nt | 0.4260 | |
| AGUCUGGCGGCGGCUGCCGUGAGCUGACUGACGUUCCGGGAACGCCGCA… | 3594 nt | 0.4210 | |
| AGUCUGGCGGCGGCUGCCGUGAGCUGACUGACGUUCCGGGAACGCCGCA… | 4017 nt | 0.4302 | |
| AGUCUGGCGGCGGCUGCCGUGAGCUGACUGACGUUCCGGGAACGCCGCA… | 3651 nt | 0.4133 | |
| AGUCUGGCGGCGGCUGCCGUGAGCUGACUGACGUUCCGGGAACGCCGCA… | 3981 nt | 0.4288 | |
| AGUCUGGCGGCGGCUGCCGUGAGCUGACUGACGUUCCGGGAACGCCGCA… | 3865 nt | 0.4266 | |
| AGUCUGGCGGCGGCUGCCGUGAGCUGACUGACGUUCCGGGAACGCCGCA… | 3829 nt | 0.4252 |
This gene encodes a mitochondrial protein that functions to enhance the cell surface expression of odorant receptors. Mutations in this gene cause spastic paraplegia autosomal dominant type 31, a neurodegenerative disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
No relevant information is available at the moment.